For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Valentia’s $15 million Indici spend turns PMS world on its head
+Print Archive
DIGITAL HEALTH
Valentia’s $15 million Indici spend turns PMS world on its head
Wednesday 12 September 2018, 02:00 AM

A view, without patient information, of what Indici will look like for practitioners
Indici is fast becoming one of the bigger players in New Zealand’s practice management systems market.
Where did it come from, and how is it changing the PMS landscape?
Fiona Thomas finds out
Practice IT: Comparative costs,
Indici – Tū Ora Compass Health practices will pay $3000 per practice per year for Indici, plus $2 per patient per year and 50 cents per patien
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.